ArticleJournal of the American Chemical Society2026
An Adaptable Porous Metal-Organic Framework for Structural Visualization of Beyond Rule of 5 Molecules on the Microgram Scale.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Beyond rule of 5 (bRo5) pharmaceutical compounds represent major structural challenges due to their large size and complexity. Here, we show that a metal-organic framework, APF-40, enables encapsulation and structural visualization of bRo5 molecules. It comprises a new benzoate-substituted hexaazaphenalene ligand and Zn8 clusters forming a doubly interpenetrated framework. The dynamic movement of the two nets facilitates adaptive behavior, efficiently immobilizing molecules along with their solvation spheres. Structures of 12 guests, including eight bRo5 compounds with subtly differing substituent modifications─ methyl-to-ethyl, methoxy-to-hydroxy, and alkane-to-alkene─were precisely elucidated. Significantly, one compound, isolated from a commercially available sample, was identified as a novel ivermectin derivative. This work demonstrates μg-order structure determination of molecules larger than 500 Da, offering new possibilities for characterizing compounds previously intractable for established analytical techniques.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.